Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Colantuono

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
The World Allergy Organization Journal|July 24, 2023
Effects of house dust mite subcutaneous immunotherapy in real-life. Immunological and clinical biomarkers and economic impact analysisCristiano Caruso, Stefania Colantuono, Barbara Tolusso, et al.
Genes and Immunity|February 19, 2020
A stereotyped light chain may shape virus-specific B-cell receptors in HCV-dependent lymphoproliferative disordersYlenia A Minafò, Martina Del Padre, Cristina Cristofoletti, et al.
Biomolecules|October 26, 2024
Aspirin Hypersensitivity in Patients with Coronary Artery Disease: An Updated Review and Practical RecommendationsLuigi Cappannoli, Stefania Colantuono, Francesco Maria Animati, et al.
Frontiers in Immunology|February 27, 2023
Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21<sup>low</sup> B cells in hepatitis C virus-cured mixed cryoglobulinemiaMartina Del Padre, Ramona Marrapodi, Ylenia A Minafò, et al.
Autoimmunity Reviews|May 17, 2011
A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infectionMarcella Visentini, Serena Ludovisi, Antonio Petrarca, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 29, 2019
Long-lasting persistence of large B-cell clones in hepatitis C virus-cured patients with complete response of mixed cryoglobulinaemia vasculitisMarcella Visentini, Martina Del Padre, Stefania Colantuono, et al.
Autoimmunity Reviews|June 3, 2015
Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic reviewMarcella Visentini, Carmine Tinelli, Stefania Colantuono, et al.
Internal and Emergency Medicine|June 12, 2020
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)Caterina Vacchi, Marcella Visentini, Laura Gragnani, et al.
Rheumatology (Oxford, England)|February 16, 2021
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progressionKrizia Pocino, Cecilia Napodano, Laura Gragnani, et al.
Hepatology (Baltimore, Md.)|August 3, 2016
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemiaLaura Gragnani, Marcella Visentini, Elisa Fognani, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
The World Allergy Organization Journal|July 24, 2023
Effects of house dust mite subcutaneous immunotherapy in real-life. Immunological and clinical biomarkers and economic impact analysisCristiano Caruso, Stefania Colantuono, Barbara Tolusso, et al.
Genes and Immunity|February 19, 2020
A stereotyped light chain may shape virus-specific B-cell receptors in HCV-dependent lymphoproliferative disordersYlenia A Minafò, Martina Del Padre, Cristina Cristofoletti, et al.
Biomolecules|October 26, 2024
Aspirin Hypersensitivity in Patients with Coronary Artery Disease: An Updated Review and Practical RecommendationsLuigi Cappannoli, Stefania Colantuono, Francesco Maria Animati, et al.
Frontiers in Immunology|February 27, 2023
Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21<sup>low</sup> B cells in hepatitis C virus-cured mixed cryoglobulinemiaMartina Del Padre, Ramona Marrapodi, Ylenia A Minafò, et al.
Autoimmunity Reviews|May 17, 2011
A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infectionMarcella Visentini, Serena Ludovisi, Antonio Petrarca, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 29, 2019
Long-lasting persistence of large B-cell clones in hepatitis C virus-cured patients with complete response of mixed cryoglobulinaemia vasculitisMarcella Visentini, Martina Del Padre, Stefania Colantuono, et al.
Autoimmunity Reviews|June 3, 2015
Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic reviewMarcella Visentini, Carmine Tinelli, Stefania Colantuono, et al.
Internal and Emergency Medicine|June 12, 2020
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)Caterina Vacchi, Marcella Visentini, Laura Gragnani, et al.
Rheumatology (Oxford, England)|February 16, 2021
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progressionKrizia Pocino, Cecilia Napodano, Laura Gragnani, et al.
Hepatology (Baltimore, Md.)|August 3, 2016
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemiaLaura Gragnani, Marcella Visentini, Elisa Fognani, et al.
Pageof 5